Model.IsUpcomingAward = False Model.IsLoggedOut=False Model.PassedInYear=2021 Model.LastYear=2024 Model.ShowLoggedOut=True
 
 
 
2021 Best In Klas
 

Drug Diversion Monitoring

 
 
 
 
A+ = >95.0
A = 91.0-94.9
A- = 88.0-90.9
B+ = 85.0-87.9
B = 81.0-84.9
B- = 78.0-80.9
C+ = 75.0-77.9
C = 71.0-74.9
C- = 68.0-70.9
D+ = 65.0-67.9
D = 61.0-64.9
D- = 58.0-60.9
F = <58.0
 
 
Ranked Solutions
Category average: 81.4
Software average: 82.4
Grading Scale

Company/solution
Overall performance score
(100-point scale)
Total
evaluations
Trend
(2020-2021)
Culture
Loyalty
Operations
Product
Relationship
Value
                   
Bluesight
Kit Check Bluesight for Controlled Substances  
KLAS comments icon
90
n=39
0%
B+
A
A-
B+
A-
A
         
 
 
 
 
 
Omnicell
Analytics  
69.7
n=25
0%
D+
C-
C
C
C
D
         
 
 
 
 
 
Bluesight
Medacist RxAuditor  
68.9
n=21
0%
B-
F
C
D
C+
C+
 
50.0
100.0
 
Company/solution
Trend
(2020-2021)
KLAS Culture Icon
Culture
KLAS Loyalty Icon
Loyalty
KLAS Operations Icon
Operations
KLAS Product Icon
Product
KLAS Relationship Icon
Relationship
KLAS Value Icon
Value
                 
Bluesight
Kit Check Bluesight for Controlled Substances
 
90
n=39
KLAS comments icon  COMMENTS
    0%
B+
A
A-
B+
A-
A
Omnicell
Analytics
 
69.7
n=25
    0%
D+
C-
C
C
C
D
Bluesight
Medacist RxAuditor
 
68.9
n=21
    0%
B-
F
C
D
C+
C+
Company/solution
 
Censinet assessment N/A
 
culture
B+
loyalty
A
operations
A-
product
B+
relationship
A-
value
A
 
KLAS comments icon  COMMENTS
Omnicell
Analytics
69.7
n=25
 
Censinet assessment N/A
 
culture
D+
loyalty
C-
operations
C
product
C
relationship
C
value
D
 
Bluesight
Medacist RxAuditor
68.9
n=21
 
Censinet assessment N/A
 
culture
B-
loyalty
F
operations
C
product
D
relationship
C+
value
C+
 
 
 
 
 
SolutionsNotRanked_Symbol  
Solutions Not Ranked
 


L      
Company/solution
Overall performance score
(100-point scale)
Total
evaluations
Culture
Loyalty
Operations
Product
Relationship
Value
                 
HelioMetrics
Drug Diversion Analytics *
L
76.5
n=9
C-
C+
C
C+
B-
B
       
 
 
 
 
 
Imprivata
FairWarning Drug Diversion Monitoring *
L
93.9
n=13
A+
A+
A-
A-
A
A+
       
 
 
 
 
 
Wolters Kluwer
Invistics Flowlytics *
L
80.2
n=6
C
B
C+
C+
A-
B+
 

L      
Company/solution
Overall performance score (100-point scale)
Total
evaluations
     
HelioMetrics
Drug Diversion Analytics *
L
culture
C-
loyalty
C+
operations
C
product
C+
relationship
B-
value
B
76.5
n=9
     
Imprivata
FairWarning Drug Diversion Monitoring *
L
culture
A+
loyalty
A+
operations
A-
product
A-
relationship
A
value
A+
93.9
n=13
     
Wolters Kluwer
Invistics Flowlytics *
L
culture
C
loyalty
B
operations
C+
product
C+
relationship
A-
value
B+
80.2
n=6
 

L      

Company/solution
HelioMetrics
Drug Diversion Analytics * L
76.5
n=9
culture
C-
loyalty
C+
operations
C
product
C+
relationship
B-
value
B
 

Imprivata
FairWarning Drug Diversion Monitoring * L
93.9
n=13
culture
A+
loyalty
A+
operations
A-
product
A-
relationship
A
value
A+
 

Wolters Kluwer
Invistics Flowlytics * L
80.2
n=6
culture
C
loyalty
B
operations
C+
product
C+
relationship
A-
value
B+
 
 
 
 
 
 
 
 

Past Drug Diversion Monitoring Awards